info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0081708-01
Couldn't load pickup availability
Selitrectinib (LOXO-195) is a next-generation TRK kinase inhibitor, with IC50s of 0.6 nM and TRKA and TRKC, respectively[1].
[2097002-61-2]
C20H21FN6O
380.42
FC1=CN=C(CC[C@H](N2)C)C([C@](CCC3)([H])N3C(C=CN4N=C5)=NC4=C5C2=O)=C1
Trk Receptor
TrkA; TrkC
10mM
99.9
DMSO : 62.5 mg/mL (ultrasonic)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H302, H315, H319, H335
Loading...
Total items
Product subtotal
Selitrectinib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.